Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT05426460
Eligibility Criteria:
Inclusion Criteria:
* Between the ages of 26 \& 55
* High treatment interest (planning to quit within the next 6 months)
* Ability to provide written informed consent
* Smoke equal or greater than 7 cigarettes per day
* Expired breath carbon monoxide (CO) equal or greater than 8 ppm at screening
* Ability to attend 10 sessions over a 3-week period, and complete 2 follow-up phone assessments
Exclusion Criteria:
* Epilepsy or Current Seizure Disorder
* Alcohol or Substance Dependence past 3 months (caffeine allowed, nicotine is part of inclusion criteria, alcohol \> 14 drinks per week (M) or \> 7 drinks per week (F))
* Implanted cardiac or brain medical devices
* History of epilepsy or current seizure disorder
* History of brain surgery or skull fracture
* History of a head trauma (losing consciousness \>10 min and/or problems with speech or movement because of head injury)
* Latex allergy
* Scalp irritation
* History of diabetes that caused loss of consciousness (\>10 min) or weakness in your arms or legs
* History of electroconvulsive therapy (ECT) in the last 5 years (Y / N) History of ECT within the last 5 years
* Current use of dextromethorphan
* Diagnosed with or undergone treatment for alcohol or substance dependence past 3 months
* Uncorrected vision deficit
* Colorblindness
* Use of tobacco products other than commercially available cigarettes
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
26 Years
Maximum Age:
55 Years
Study:
NCT05426460
Study Brief:
Protocol Section:
NCT05426460